Newsletter

Int. Rev. Allergol. Clin. Immunol. Family Med., 2018, XXIV/1: 042-046 Maximize

Int. Rev. Allergol. Clin. Immunol. Family Med., 2018, XXIV/1: 042-046

Title: The use of platelet-rich plasma in the treatment of degenerative and post-traumatic changes 

Authors: Szymczak Z, Dudek J, Płusa T, Częstochowska B, Michalski P. 

More details

05-01-2018

40,00 zł

SUMMARY IN POLISH & ENGLISH. FULL ARTICLE ONLY IN POLISH.

The use of platelet-rich plasma in the treatment of degenerative and post-traumatic changes


Szymczak Z1, Dudek J1, Płusa T2, Częstochowska B1, Michalski P1.

1Orthopedic Subunit of the Neuroortopedic Department, Mazowian Rehabilitation Center „STOCER” Konstancin-Jeziorna, Poland; 2Medical Faculty of Łazarski University in Warsaw, Poland

Int Rev Allergol Clin Immunol Family Med, 2018; Vol. 24, No. 1, 042

According to the data of the World Health Organization, the number of changes in the musculoskeletal system affects many millions of people. Degenerative changes of the joints, which do not require surgical treatment, can be treated conservatively. Since 1998, attention has focused on the preparation of platelet-rich plasma (PRP), which is prepared individually from the patient’s blood. An increased number of plaques in PRP causes the growth factors contained therein to be released in large amounts, affecting the structure of cartilage and connective tissue cells. As a result, PRP preparations were also used in orthopedics.

Key words: platelet-rich plasma, osteoarthritis changes